Publication | Open Access
New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position
44
Citations
11
References
1998
Year
Bioorganic ChemistryGastrointestinal PharmacologyDual CyclooxygenasePharmacotherapyNew Cyclooxygenase-2/5-lipoxygenase InhibitorsPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry5-Keto-substituted 7-Tert-butyl-2,3-dihydro-3,3-dimethylbenzofuransAnti-cancer AgentDerivativesBiochemistryAnalgesic AgentsPharmacological AgentGastrointestinal Safe AntiinflammatoryDrug DevelopmentPharmacologyAnti-inflammatoryNatural SciencesInitial DiscoveryMedicineDrug Discovery
We report an expansion of the scope of our initial discovery that 5-keto-substituted 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofurans (DHDMBFs) are antiinflammatory and analgesic agents. Several other functional groups have been introduced at the 5 position: amides, amidines, ureas, guanidines, amines, heterocycles, heteroaromatics, and heteroaryl ethenyl substituents in the 5 position all provide active compounds. These compounds are dual cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) inhibitors. They inhibit both COX-1 and COX-2 with up to 33-fold selectivity for COX-2.
| Year | Citations | |
|---|---|---|
1986 | 3.4K | |
1992 | 192 | |
1967 | 172 | |
1994 | 162 | |
1991 | 91 | |
1952 | 83 | |
1980 | 62 | |
1983 | 36 | |
1986 | 33 | |
1986 | 23 |
Page 1
Page 1